Elelyso

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ELELYSO® taliglucerase alfa rpc Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Elelyso. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All […]

Roferon-A

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Roferon-A pre-filled syringes. It does not contain all the available information. It does not take […]

Scientists propose a new approach to assessing platelet activation risk

Researchers from Moscow Institute of Physics and Technology together with their colleagues from National Research Center for Hematology have developed a new method for assessing individual risks of intravascular platelet activation. The latter plays a crucial role in the development of various serious clinical situations such as heart attacks and strokes. The range of circumstances […]